thiazoles has been researched along with Chromosome Deletion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kameoka, Y; Kume, M; Nagao, T; Noguchi, S; Ohyagi, H; Sawada, K; Shinohara, Y; Takahashi, N | 1 |
| Aloyz, R; Amrein, L; Gibson, SB; Johnston, JB; Panasci, L; Soulières, D | 1 |
1 review(s) available for thiazoles and Chromosome Deletion
| Article | Year |
|---|---|
Dasatinib-responsive chronic lymphocytic leukemia in a patient treated for coexisting chronic myeloid leukemia.
Topics: Aged, 80 and over; Antineoplastic Agents; Chromosome Deletion; Chromosome Disorders; Chromosomes, Human, Pair 13; Dasatinib; Female; Genes, abl; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasms, Multiple Primary; Protein Kinase Inhibitors; Pyrimidines; Thiazoles | 2013 |
1 other study(ies) available for thiazoles and Chromosome Deletion
| Article | Year |
|---|---|
Primary del 17 chronic lymphocytic leukaemia lymphocytes are hypersensitive to dasatinib in vitro.
Topics: Chromosome Deletion; Chromosomes, Human, Pair 17; Dasatinib; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Protein Kinase Inhibitors; Pyrimidines; Thiazoles; Tumor Cells, Cultured | 2009 |